insights_auto
Why is AGIO down ३.३४%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ ३०.५४
arrow_downward
-३.३४%(-१.०६) 1D
नोभेम्बर १६, १५:३०:५० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ ३१.२९
High
US$ ३१.७०
Low
US$ ३०.३६
Mkt. cap
१.८३ अरब
Avg. vol.
१२.४२ लाख
Volume
२.२५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ ३१.२९
High
US$ ३१.७०
Low
US$ ३०.३६
Mkt. cap
१.८३ अरब
Avg. vol.
१२.४२ लाख
Volume
२.२५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
ChartMill
·
२५ मिनेट पहिले
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Investor's Business Daily
·
१ घण्टा पहिले
Tyson, Starbucks Lead The S&P 500, Nasdaq 100 As Investors Play Defense
Investing.com
·
३४ मिनेट पहिले
Why is SPDR S&P 500 ETF sliding today?
FXStreet
·
३ घण्टा पहिले
The S&P 500 will find a new leader
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc